Comparison of Empaglifozin and Vildagliptin in Type 2 Diabetes Mellitus

NCT05359432 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

120

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes

Interventions

DRUG: Empagliflozin
DRUG: Vildagliptin

Sponsor

Getz Pharma